Caltrate Products

Promotion of Access to Information Act (PAIA)

The PAIA manual is prepared in accordance with section 51 of the Promotion of Access to Information Act (PAIA) No. 2 of 2000 (as amended) and the Protection of Personal Information Act, 2013. The purpose of PAIA is to promote the right of access to information, to foster a culture of transparency and accountability within the Company by giving the right to information that is required for the exercise or protection of any right and to actively promote a society in which the people of South Africa have effective access to information to enable them to exercise and protect their rights.

Please see the PAIA manuals.

References: 1. Nicholas Hall’s Global CHC database, DB6, MAT Q2 2022 value data.

S0 Caltrate 600+D: Each tablet contains: Elemental Calcium 600 mg, Vit. D 400 IU.

S0 Caltrate Plus: Each tablet contains: Elemental Calcium 600 mg, Vit. D 500 IU, Magnesium 40 mg, Zinc 7,5 mg, Copper 0,5 mg, Manganese 1,8 mg.

S0 Caltrate Plus chewable: Each tablet contains: Elemental Calcium 600 mg, Vit. D 500 IU, Magnesium 40 mg, Zinc 7,5 mg, Copper 0,25 mg, Manganese 1,8 mg, Boron 70 mcg.

Complementary medicines – Health Supplement. This unregistered medicine has not been evaluated by the SAHPRA for its quality, safety or intended use.

GlaxoSmithKline Consumer Healthcare South Africa (Pty) Ltd.

39 Hawkins Avenue, Epping Industria 1, Cape Town, 7460. Reg. No: 2014/173930/07.

For full prescribing information refer to the patient information leaflet

For any further information, including safety, please contact us on 0800 007 018 or email mystory.za@haleon.com

Our Privacy policy Haleon Privacy Centre.

Always Read label before use

Trademarks are owned by or licensed to GSK group of companies.

This page is sponsored by GSK Consumer Healthcare

Promotional material number PM-ZA-CAL-23-00001, PM-ZA-CAL-23-00002.